Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Incubus post #54180 thoroughly spelled out that sm

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 380)
Posted On: 03/21/2019 3:54:14 PM
Posted By: Mo
Incubus post #54180 thoroughly spelled out that smokenhot’s earlier post today was not clearly written so I have nothing further to add to that regarding today’s food-fight. I did find it interesting that Lemoncat quickly came to smokenhot’s defense and started bashing Drano when he correctly pointed out a flawed post. I found it interesting that Lemoncat was defending a poster he called “smokenscott” and who called him a “bozo”. I am wondering if it would be less confusing to themselves if they stuck to the roles of good basher/ bad basher?
=========================================================================================
Posted On: 03/21/2019 11:32:44 AM

Posted By: Lemoncat
Re: Drano #54153
He was talking about the interval/frequency of the Cisplatin dosing - the only thing different about the two non-placebo B-OM arms. I think it was very clear to anyone who understands the B-OM trial.


Read More: https://investorshangout.com/post/view?id=538...z5ipugntwy


Posted On: 02/28/2019 4:59:29 PM

Posted By: Lemoncat
Smokenscott should be ignored.

Read More: https://investorshangout.com/post/view?id=536...z5ipkwXjEz
Posted On: 03/12/2019 6:57:06 PM



Posted By: smokenhot
Re: Lemoncat #53888
Lemon if Kevetrin could activate p53 in 20% of patients without sae that would be considered amazing since there is NO drug that can do that today.

Well guess what those 2 patients are 20% at a minimal that the trial(10) would have showed.

It was a tough tough patient population to get volunteers from.
A pill form will make it EZ to administer and Kevetrin will show it's true worth to bozo's like yourself.

Read More: https://investorshangout.com/post/view?id=537...z5iptkZgCn


(5)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us